Who is Jean-Pierre Latere, the Congolese scientist and entrepreneur at the heart of a $1 billion deal with AstraZeneca?
In 2021, Belgian Jean-Pierre Latere Dwan’Isa, originally from the Democratic Republic of the Congo, founded EsoBiotec, a visionary company that is reinventing in vivo cell therapy to make cancer treatments both more accessible and more powerful. This revolutionary innovation has now caught the attention of AstraZeneca, which is ready to acquire the company for a […]
Lire la suite